Liontos M

ORCID: 0000-0001-7192-4575 · 3 papers in corpus
review 2025
Biomedicines ·doi:10.3390/biomedicines13112820

Ovarian cancer is the gynecologic malignancy that bears the highest mortality rate in the Western world. This is attributed to late diagnosis and limited therapeutic progress. Recent advances in molecular oncology have highlighted the pivot…

meta-analysis 2025
Current oncology (Toronto, Ont.) ·doi:10.3390/curroncol32050251

Uterine serous carcinomas are an aggressive minority of endometrial cancers. They are characterized by mutations in TP53 and extensive copy number alterations and are primarily classified in the copy number-high/p53abn molecular prognostic …

observational 2022
Frontiers in oncology ·doi:10.3389/fonc.2022.1030786

BACKGROUND: Germline BRCA1/2 mutations are identified in 13-15% of ovarian cancers, while an additional 5-7% of ovarian cancers harbor somatic BRCA1/2 mutations. Beyond these mutations, germline or somatic aberrations in genes of the homolo…